Variant report
Variant | esv1817460 |
---|---|
Chromosome Location | chr9:11630528-11660139 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs149325794 | chr9:11631201-11631202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs75739917 | chr9:11631213-11631214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs537239833 | chr9:11631222-11631223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs144581125 | chr9:11631251-11631252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs573966961 | chr9:11631257-11631258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs534062970 | chr9:11631285-11631286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs148460764 | chr9:11631293-11631294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs75705769 | chr9:11631299-11631300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs73397505 | chr9:11631302-11631303 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs142630916 | chr9:11631319-11631320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs187547348 | chr9:11631345-11631346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541533705 | chr9:11631348-11631349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs373851095 | chr9:11631396-11631397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571962609 | chr9:11631414-11631415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541056034 | chr9:11631453-11631454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs191314451 | chr9:11631454-11631455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543627587 | chr9:11631462-11631463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573658539 | chr9:11631463-11631464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs368131854 | chr9:11631476-11631477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs147610590 | chr9:11631495-11631496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs550389548 | chr9:11631512-11631513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542679137 | chr9:11631519-11631520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs182423753 | chr9:11631531-11631532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529362671 | chr9:11631541-11631542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549523401 | chr9:11631547-11631548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566027642 | chr9:11631582-11631583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140020997 | chr9:11631604-11631605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs551778810 | chr9:11631609-11631610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570650646 | chr9:11631665-11631666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs553022097 | chr9:11631706-11631707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs28594665 | chr9:11631712-11631713 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs555899342 | chr9:11631740-11631741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs28546126 | chr9:11631762-11631763 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs113618804 | chr9:11631796-11631797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555154074 | chr9:11631803-11631804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs572135243 | chr9:11631810-11631811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs540668930 | chr9:11631820-11631821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557776434 | chr9:11631824-11631825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs538339417 | chr9:11631837-11631838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs578240267 | chr9:11631849-11631850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs192763537 | chr9:11631852-11631853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs559146689 | chr9:11631861-11631862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563847535 | chr9:11631862-11631863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529523393 | chr9:11631883-11631884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs73643983 | chr9:11631911-11631912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs368592745 | chr9:11631923-11631924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs369039454 | chr9:11631931-11631932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs559569333 | chr9:11631936-11631937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs527578931 | chr9:11632019-11632020 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528631463 | chr9:11632029-11632030 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Schizophrenia | 18511947 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:11631200-11632200 | Enhancers | Fetal Brain Male | brain |
2 | chr9:11631400-11632000 | Enhancers | Fetal Brain Female | brain |
3 | chr9:11632000-11633000 | Weak transcription | Fetal Brain Female | brain |
4 | chr9:11632200-11633200 | Weak transcription | Fetal Brain Male | brain |
5 | chr9:11633000-11633200 | Enhancers | Fetal Brain Female | brain |
6 | chr9:11633200-11633600 | Enhancers | Fetal Brain Male | brain |
7 | chr9:11650200-11650600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr9:11656000-11656800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |